newsfilter
← Latest News
PR Newswire·

DURECT Corporation Announces Presentations in Upcoming Investor Conferences

CUPERTINO, Calif., Aug. 31, 2023 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel